IKZF1 deletion [46] and biallelic loss of CDKN2A [47] are poor prognostic factors in ALL and are more frequently observed in refractory ALL patients than in newly diagnosed ALL cases [48]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.